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Abstract
Dengue fever induces a robust immune response, including massive T cell activation. The
level of T cell activation may, however, be associated with more severe disease. In this
study, we explored the level of CD8+ T lymphocyte activation in the first six days after onset
of symptoms during a DENV2 outbreak in early 2010 on the coast of São Paulo State, Bra-
zil. Using flow cytometry we detected a progressive increase in the percentage of CD8+
T cells in 74 dengue fever cases. Peripheral blood mononuclear cells from 30 cases were
thawed and evaluated using expanded phenotyping. The expansion of the CD8+ T cells
was coupled with increased Ki67 expression. Cell activation was observed later in the
course of disease, as determined by the expression of the activation markers CD38 and
HLA-DR. This increased CD8+ T lymphocyte activation was observed in all memory sub-
sets, but was more pronounced in the effector memory subset, as defined by higher CD38
expression. Our results show that most CD8+ T cell subsets are expanded during DENV2
infection and that the effector memory subset is the predominantly affected sub population.
Author Summary
Dengue is a disease affecting approximately 400 million people annually, especially in tropi-
cal and subtropical areas of the globe. The immune response against the dengue virus is still
under investigation and it is important to understand why the disease can be fatal in a small
proportion of cases. In this work, we explored how an important cell type of the immune
system, namely the CD8+ T cell, reacts during dengue infection. Using a method known as
flow cytometry, we demonstrated that these cells expand and become highly activated, dur-
ing the days following the onset of dengue fever symptoms. This expansion is associated
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003520 February 12, 2015 1 / 14
OPEN ACCESS
Citation: de Matos AM, Carvalho KI, Rosa DS,
Villas-Boas LS, da Silva WC, Rodrigues C, et al.
(2015) CD8+ T Lymphocyte Expansion, Proliferation
and Activation in Dengue Fever. PLoS Negl Trop Dis
9(2): e0003520. doi:10.1371/journal.pntd.0003520
Editor: Eva Harris, University of California, Berkeley,
UNITED STATES
Received: November 13, 2011
Accepted: January 5, 2015
Published: February 12, 2015
Copyright: © 2015 de Matos et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The present work was supported by the
Conselho Nacional de Desenvolvimento Cientifico e
Tecnologico, Brazilian Ministry of Science and
Technology (CNPq, grant #476088/2009-7 to EGK).
AMM and EGK’s scholarships were supported by
CNPq. KIC’s scholarship was supported by the
Coordenação de Aperfeicoamento de Pessoal de
Nível Superior, Brazilian Ministry of Education. URL
of CNPq: URL www.cnpq.br; URL of CAPES: www.
capes.gov.br. The funders had no role in study
with a decreased dengue virus load in the patients’ blood, suggesting that CD8+ T cells play
an important role in viral control. Interestingly, we found that a subset of CD8+ T cells,
called effector memory, is greatly expanded during dengue infection. Our results are impor-
tant because they might contribute to the understanding of disease mechanisms during
dengue infection and may help in the development of a novel vaccine against dengue.
Introduction
Dengue is the most prevalent arthropod-born viral disease in tropical and subtropical areas of
the globe, affecting approximately 400 million people annually [1]. The World Health Organi-
zation estimates that nearly 40% of the world’s population lives in areas at risk for dengue
transmission. Dengue cases in Central and Latin America have increased almost five-fold in
the last 30 years. During 2008, up to one million cases were reported in Americas, and higher
numbers of deaths were documented in the South [2]. In the latest decades, Brazil has been
hard hit by the disease, accounting for more than 60% of the total reported cases in the Ameri-
cas [2]. The continuing occurrence of the disease in resource limited countries and the lack of
novel therapeutic approaches or a highly effective vaccine make dengue fever a neglected dis-
ease. Surveillance for dengue is absent in most countries, and no existing model for predicting
an outbreak in endemic regions is widely available. Therefore, it is important to increase our
knowledge of disease pathogenesis, with the goal of developing new strategies to fight
the epidemic.
The mechanisms by which the dengue virus (DENV) causes severe illness remain to be elu-
cidated. Both biological properties of the viral isolates and immunogenic host factors seem to
contribute to the level of pathogenicity [3,4,5,6]. Whereas immunity induced by natural infec-
tion is believed to provide serotype-specific lifelong protection, previous infection by a distinct
serotype is considered to increase the risk for the development of dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS) [5,7]. The immunological processes during dengue
infection are not yet completely defined. However, incidence of mild dengue manifestations
and occasional progression to the more severe disease likely reflect a complex interplay be-
tween host and viral factors including cytokine production by inflammatory cells. Previous
studies reported increased levels of circulating cytokines and soluble receptors in DHF patients
when compared to those with dengue fever (DF), suggesting that immune activation may be re-
lated to disease severity [8]. T cell activation mechanisms are based on the binding of specific
T cell receptors (TCRs) to MHC molecules [9]. CD8+ T cells are one of the most important cell
types to recognize and eliminate infected cells. Some authors have suggested that high numbers
of CD8+ T cells might be protective by reducing viral load [10]. Memory T lymphocytes re-
main present in the absence of antigenic stimulation and have the capacity to expand rapidly
upon secondary challenge. In the last decade, several surface markers have been used to distin-
guish among effector memory (TEM), central memory (TCM), and terminally differentiated
memory cells (TEMRA) [11]. In this work, we explored the state of CD8+ T cell activation in
different compartments during the acute phase of dengue fever.
Methods
Ethics statement
All procedures adopted in this study were performed according to the terms agreed by the In-
stitutional Review Board from the Hospital das Clínicas, University of São Paulo (CAPPesq—
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Research Projects Ethics Committee). This study was approved by CAPPesq under protocol
0652/09. Written informed consents were obtained from all study volunteers.
Clinical samples
Whole-blood samples were collected, using sterile EDTA-treated Vacutainer tubes (BD Brazil),
from patients with DENV2 dengue at the Ana Costa Hospital, Santos, State of São Paulo, dur-
ing the 2010 first semester outbreak [12]. Patients with suspected dengue fever, dengue with
warning signs or severe dengue were invited to participate in the study. A rapid rest was per-
formed to confirm the diagnosis of acute dengue disease, followed by the detection of dengue
viral load determination (see next sections). Primary dengue infection was considered when
dengue IgG-specific antibodies were not detected in the presence of reactive dengue IgM-
specific antibody and/or NS1 antigenemia. Secondary dengue infection was considered in the
presence of dengue IgG-specific antibodies at acute phase up to 6 days of symptoms.
Serology
A commercial Dengue Duo Test Bioeasy (Standard Diagnostic Inc. 575–34, Korea), a rapid test
kit, was used for dengue diagnosis, by detection of both dengue virus NS1 antigen and IgM-
and IgG-specific antibodies in human blood. Samples were considered positive for acute den-
gue fever when NS1 or IgM bands were reactive in the testing kit. We also considered an acute
case whenever DENV2 RNA was detected.
Dengue viral load determination
The IgG avidity test was used to determine if patients presented with a primary or secondary
DENV infection [13]. Samples with low avidity IgG antibodies were classified as primary
DENV infection, whereas samples with high avidity IgG antibodies were classified as second-
ary. Samples in which IgG antibodies were not detected could not be classified, although the
majority were probably from primary DENV infection. Viral load was determined by an “in-
house” real-time polymerase chain reaction (RT-PCR) method. RNA was extracted from
140μL of plasma using the Qiagen Viral RNA kit (Qiagen, USA). All RT-PCR reactions were
performed in duplicate. RT-PCR was conducted using the SuperScript III Platinum SYBR
Green One-Step qRT-PCR kit with ROX (Invitrogen, USA) and 0.4 μM of primers covering all
four DENV serotypes [14]. Cycling conditions were: 10 minutes reverse transcription at 60°C,
1 min Taq polymerase activation at 95°C, followed by 45 cycles consisting of 95°C without
holding time, 60°C for 3 seconds, and 72°C for 10 seconds. The reaction was run on an ABI
7300 RT-PCR equipment (Applied Biosystems, Brazil). As an internal control Bovine Diarrhea
Virus (BDV) was added to the samples before RNA extraction and also run in a parallel RT-
PCR assay. Supernatant from DENV-3 cell cultures was included as an external control.
DENV-3 supernatant was previously quantified by a commercial dengue RT-PCR kit (RealArt;
artus/QIAGEN, Germany) [15] and used to generate a standard curve. The detection limit of
this assay was 100 copies/ml.
CD4+ and CD8+ T cell counting
Peripheral blood absolute CD4+ and CD8+ T cell counts were assessed using the BDMultitest
CD3-FITC/CD8-PE/CD45-PerCP/CD4-APC monoclonal antibody (mAb) cocktail from BD
Biosciences (San Diego, CA), according to the manufacturer’s instruction, using a FACSCanto
flow cytometer (BD Biosciences). Cell surface staining was routinely performed on 100 μL
fresh whole blood.
CD8+ T Activation in Dengue Fever
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003520 February 12, 2015 3 / 14
Surface immunophenotyping in flow cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from fresh EDTA-treated blood by
Ficoll-Hypaque gradient centrifugation and frozen in liquid nitrogen as previously described
[16]. PBMC were isolated from volunteers and stored in liquid nitrogen until used in the as-
says. To characterize the activation profile of CD8+ T lymphocytes, we used the markers HLA
DR and CD38. HLA DR is a transmembrane glycoprotein encoded by genes within the Human
Leucocyte Antigen (HLA) complex. CD38 is a nonlineage-restricted type II transmembrane
glycoprotein that has emerged as a multifunctional protein. Cells expressing both markers are
likely to be activated. The following monoclonal antibodies were used in the FACS assays: anti-
CD8-peridin chlorophyll protein (PerCP) (clone SK1), CD45RA-fluorescein isothiocyanate
(FITC) (clone L48), CD38-phycoerythrin (PE) (clone HB7), from BD Biosciences (San Jose,
CA, USA); CCR7-phycoerythrin—cyanine (PE-Cy7) (clone 3D12), HLADR-Alexa 700 (clone
L243), CD27-APCH7 (clone M-T271), CD4-Pacific Blue (clone RAPA-T4), from BD Phar-
mingen (San Jose, CA, USA); CD3-ECD (clone UCHT1), from Beckman Coulter (Marseille,
France) and Fixable Aqua dead cell stain kit, fromMolecular Probes (Oregon, USA).
After thawing, cells were centrifuged at 1,500 rpm for 5 minutes and transferred into 96 V
bottom well plates (Nunc, Denmark) in 100 L of staining buffer (PBS supplemented with 0.1%
sodium azide [Sigma] and 1% FBS, pH 7.4–7.6) with the surface monoclonal antibodies panel.
Cells were incubated at 4C in the dark for 30 minutes, washed twice, and resuspended in 100 L of
fixation buffer (1% paraformaldehyde Polysciences, Warrington, PA in PBS, (pH 7.4–7.6). Fluo-
rescence minus one (FMO) was used for gating strategy [17]. The strategy is shown in S1 Fig.
Intracellular staining in flow cytometry
CD8+ T cell proliferation was assessed using a Ki67 staining protocol. Ki67 is a cell-cycle-asso-
ciated antigen expressed exclusively in proliferating cells. After staining with surface markers
CD3-PERCP (clone SK7), CD8-allophycocyanin cyanine-7 (APC-Cy7) (clone SK7), from BD
Biosciences (San Jose, CA, USA); CD4-Alexa 700 (clone RAPA-T4), from BD Pharmingen
(San Jose, CA, USA) and Fixable Aqua dead cell stain kit, as described above, cells were fixed
with 4% fixation buffer for 10 minutes. Cells were washed with staining buffer once and re-sus-
pended in 100 L of permeabilization buffer from BD Biosciences (San Jose, CA, USA) and incu-
bated for 15 minutes. Cells were washed with staining buffer twice. Ki-67-FITC (clone B-56)
was added and cells incubated at 4C in darkness for 30 minutes. Finally, the cells were washed
twice, and re-suspended in 100 L of 1% fixation buffer.
Samples were acquired on a FACSFortessa, using FACSDiva software (BD Biosciences), and
then analyzed with FlowJo software version 9.4 (Tree Star, San Carlo, CA). Fluorescence volt-
ages were determined using matched unstained cells. Compensation was carried out with
CompBeads (BD Biosciences) single-stained with. Samples were acquired until at least 200,000
events were collected in a live lymphocyte gate. The analysis strategy is shown in S2 Fig.
Statistical analysis
Because most continuous variables presented an overdispersed distribution, results were sum-
marized as medians and 25% to 75% interquartile ranges (IQR) and compared across dengue
patient groups and non exposed controls, using nonparametric Kruskal-Wallis or Mann-
Whitney tests (continuous variables). When the Kruskal-Wallis test indicated a statistically sig-
nificant difference (P<0.05) among more than two groups, a Dunn’s multiple comparison
post-tests was carried out to determine between which groups the differences were sustained.
Potential correlations were explored using Spearman rank correlation tests. The software
Prism, version 5.0, was used for analyses (GraphPad Software, San Diego, CA).
CD8+ T Activation in Dengue Fever
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Results
Subjects and cell blood counts
Peripheral venous blood was obtained from 74 patients with acute dengue fever and 17
matched donors who were asymptomatic and negative for DENV IgM, NS1, and RNA. The
characteristics of the dengue fever patients and healthy controls are depicted in Table 1. No
differences were seen in gender and age distribution comparing both groups. As expected,
dengue fever patients had lower number of platelets (median 152,000 cells/μl, interquartile
range 25%–75% [IQR], 110,000–207,000) when compared to controls (median 226,000
cells/μl, IQR, 166,000–310,000), p<0.0001. Platelets decreased during the first days of dis-
ease, with a median of 174,000 cells/μl (IQR, 147,000–232,000) on days 1 and 2, 153,000
cells/μl (IQR, 115,000–206,000) on days 3 and 4, and 94,000 cells/μl (IQR, 28,000–154,000)
on days 5 and 6 after the onset of symptoms.
Overall leukocyte counts were also lower (median 4,400 cells/μl, IQR, 3,275–6,400) com-
pared to controls (median 8,100 cells/μl, IQR, 6,140–9,335), p<0.0001. Numbers were lower
on days 1 and 2 (median 5,100 cells/μl, IQR, 3,750–6,450) and 3 and 4 (median 3,600 cells/μl,
IQR, 3,100–5,100), p<0.001, but recovered on days 5 and 6 to levels of the control group.
A subset of 30 dengue fever patients (Table 2) was selected for expanded immunophenotyp-
ing experiments. To be representative of the disease natural history after onset of symptoms, 10
of these patients were at days 1 and 2, 10 patients at days 3 and 4, and 10 patients at days 5 and
6, as detailed in Table 2, along with 17 healthy controls.
CD8+ T lymphocytes numbers increase late in the course of acute
dengue fever
We first evaluated the percentages and the absolute numbers of CD8+ T lymphocytes in acute
dengue fever patients. As shown in Fig. 1A, the percentage of CD8+ T cells of overall circulat-
ing lymphocytes remained constant up to the fourth day after onset of symptoms. However,
this percentage increased on days 5 and 6, with an increased median of 38%, IQR, 29–53
(p<0.05), and this was higher than observed in healthy controls.
Absolute numbers of CD8+ T cells were lower from the first to the fourth days after onset of
symptoms (median 253 cells/μl, IQR, 151–358 for days 1 and 2; median 201 cells/μl, IQR, 158–
345 for days 3 and 4) when comparing dengue patients with healthy controls (median 465
cells/μl, IQR, 329–605). On the fifth and sixth days, we observed a higher number of cells (me-
dian 534 cells/μl, IQR, 285–1644), with wider distribution values (Fig. 1B).
Table 1. Demographic characteristics of dengue patients and healthy donors.
Characteristics DENV infection (n = 74) Healthy Donors (n = 17)
Age, in years (Median and IQR*)
Female 44 (31–54) 40 (34–55)
Male 38 (30–47) 25 (23–31)
Gender (%)
Female 58 65
Male 42 35
* Interquartile Range 25%- 75%
doi:10.1371/journal.pntd.0003520.t001
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Dengue viral load inversely correlated with the number of CD8+ T cells
Dengue viral load was evaluated in the course of dengue fever. As expected, higher viral loads
were observed in the first and second days after onset of symptoms, as shown in Fig. 2A, de-
creasing thereafter. Remarkably, dengue viral load negatively correlated with the number of cir-
culating CD8+ T lymphocytes. As demonstrated in Fig. 2, we observed that higher viral load
was seen only when CD8+ T lymphocytes remained below 450 cells/μl (arbitrary dotted line
parallel to the y axis), whereas higher CD8+ T lymphocyte counts were associated with Dengue
viral load bellow 1,050 copies/ml (arbitrary dotted line parallel to the x axis). These results
imply that these CD8+ T cells may be playing a role in the control of DENV replication in the
acute phase of disease. Of note, statistically significant correlations (p<0.05) were seen on days
1 and 2 (r = -0.6) (Fig. 2B) and on days 5 and 6 (r = -0.5) (Fig. 2D). In contrast, no correlation
was observed on days 3 and 4 (Fig. 2C).
Table 2. Demographic and hematologic characteristics of study participants.
Identiﬁcation
Number
Gender Days of
Symptoms
Age
(years)
Dengue Duo
NS1/IgM/IgG
DENV* Load
(copies/ml)
Platelets
(cells/μl)
Lymphocyte
count (cells/μl)
T cell
count
(cells/μl)
CD8+ T cell
count
(cells/μl)
5 F 6 77 - / + / + 284 10.000 3136 2684 1839
6 M 5 27 - / + / + 87 42.000 1500 665 120
7 F 5 67 - / + / + 84 56.000 6201 4545 1882
14 F 1 35 - / + / + 107 253.000 1779 1315 310
15 F 6 53 - / + / + 141 42.000 4264 3164 1826
26 M 4 46 + / + / + 11994 237.000 1168 710 375
27 F 4 29 - /—/ - 666 216.000 974 731 139
29 F 1 55 - /—/ - 2840000 113.000 644 411 186
31 F 1 31 + /—/ - 45839 147.000 840 659 182
32 M 1 26 - /—/ - 59 234.000 2126 1490 666
34 M 3 50 + /—/ - 14200000 158.000 2236 1623 268
35 F 4 37 - /—/ - 164 149.000 2349 1724 386
37 F 2 46 - /—/ - 896004 132.000 792 602 147
40 F 6 37 - / + / + 0 152.000 1963 1627 542
41 F 3 30 - /—/ - 114 361.000 2141 1674 465
45 M 5 53 - / + / + 0 20.000 2368 1428 416
58 F 2 24 - /—/ + 352 297.000 4132 2835 998
65 M 5 49 + / + / - 205151 119.000 1190 499 191
66 M 2 30 - / + / + 1983 237.000 1285 1086 443
67 M 3 33 - /—/ - 11828 137.000 986 621 207
69 M 2 56 - /—/ - 20700000 122.000 955 716 298
70 F 3 50 - /—/ - 383 255.000 1680 1211 345
71 M 6 27 + / + / + 265 237.000 1418 1106 310
98 F 5 22 - /—/ + 858 71.000 2436 1898 970
99 F 3 83 + /—/ - 1680000 127.000 1605 1445 352
100 F 1 31 - /—/ - 188 222.000 2139 1546 540
102 F 2 26 - /—/ - 7370000 154.000 992 675 152
106 F 4 82 - / + / + 400455 10.000 2442 1702 175
111 F 4 54 + / + / + 674 95.000 1343 1121 294
138 F 6 70 - / + / + 237 24.000 2419 1340 331
* DENV: dengue virus
doi:10.1371/journal.pntd.0003520.t002
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CD8+ T lymphocytes express Ki67 later in dengue fever
Samples from 30 patients with dengue fever were selected for the remaining experiments. The
aim was to be representative of the disease natural history, up to six days after onset of symp-
toms. Results are shown for days 1 and 2 (10 patients), 3 and 4 (10 patients), and 5 and 6 (10
patients), as detailed in Table 2. These were compared to the 17 healthy controls.
We observed that more CD8+ T lymphocytes expressed Ki67 in dengue fever cases when
compared to controls, either expressed in absolute numbers or percentage of stained cells (me-
dian 14 cells/μl, IQR, 7–40 vs. 4 cells/μl, IQR, 3–12, p = 0.002; median 4%, IQR, 2–14 vs. medi-
an 1%, IQR, 1–2, p<0.0001). However, this increase in expression was largely seen on days 5
and 6 (median 113 cells/μl, IQR, 21–418 and median 20%, IQR, 10–31), suggesting that these
cells proliferate later in the course of the disease (Fig. 3).
Effector memory CD8+ T lymphocytes activate later in the course of
dengue fever
We addressed the levels of CD8+ T lymphocytes activation using surface staining for CD38
and HLA-DR. Coinciding with CD8+ T lymphocyte expansion and proliferation, higher cell
activation could be detected later in the course of disease, on days 5 and 6, compared to con-
trols either in percentages (median 34%, IQR, 20–59 vs. median 3, IQR, 3–5, p<0.0001) or in
absolute numbers (median 114 cells/μl, IQR, 45–1110 vs. median 14 cells/μl, IQR, 12–21,
p<0.0001), as depicted in Fig. 4.
The cellular activation profile was different among the subpopulations of CD8+ T lympho-
cytes. Using comprehensive staining panels, we did not observe statistically significant differ-
ences in activation of naïve cells (Fig. 5A and 5B). On the other hand, higher activation was
Fig 1. CD8+ T lymphocytes in the course of dengue fever. (A) Percentage within T cells and (B) absolute numbers of CD8+ T lymphocytes in the
peripheral blood from healthy controls (n = 17) and dengue fever patients at different days of symptoms (n = 74). A significant change in the percentage of
CD8+ T lymphocytes was observed, between days 5 and 6 after the onset of symptoms when compared to healthy controls and days 3 and 4 of symptoms,
as shown in A. However, decreased absolute CD8+ T lymphocyte numbers were documented in the first four days of symptoms when compared to healthy
controls, returning to higher levels later in the disease’s course, as shown in B. *p< 0.05, ** p<0.01.
doi:10.1371/journal.pntd.0003520.g001
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observed on days 5 and 6 in the central memory (TCM), effector memory (TEM), and termi-
nally effector memory (TEMRA) cell percentages (Fig. 5C, 5E, and 5G, respectively). Neverthe-
less, this effect was only seen in the TEM subpopulation when absolute numbers were
evaluated (Fig. 5F), suggesting that TEM cells are largely responsible for this phenomenon. We
also observed that the TEM CD8+ T cell subset was negatively correlated with DENV viral
load, suggesting that the activation of such particular phenotype may have a central role in con-
trolling virus replication; however, given the post-hoc nature of this analysis this result needs
to be interpreted with caution, requiring confirmatory experiments.
Fig 2. Correlation of CD8+ T lymphocyte numbers and DENV viral load. In A, viral load was determined on different days of symptoms and a significant
decrease was observed in days 5 and 6 when compared to days 1 and 2 after the onset of symptoms (p value = 0.0136). In B, a negative correlation was
observed between 1 and 2 days of symptoms (r = -0.5900, p = 0.0019). There is no correlation between 3 and 4 days of symptoms (C) and viral loads; In D, a
negative correlation was observed between viral loads and 5 and 6 days of symptoms (r = - 0.4705, p = 0.0488). Dashed lines are arbitrarily set at 450 CD8+
T lymphocytes/μL and 1050 copies of RNA/ml.
doi:10.1371/journal.pntd.0003520.g002
CD8+ T Activation in Dengue Fever
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Discussion
Changes in lymphocyte subsets in dengue fever have long been recognized, including an in-
crease in CD8+ T lymphocyte numbers [8,18,19]. Using samples collected in a DENV2 out-
break in the coast of the State of São Paulo, Brazil [12], we were able to demonstrate that the
percentage CD8+ T cell count increased later in the course of disease, after onset of symptoms.
This was associated with higher Ki67 expression, suggesting a proliferative rebound that fol-
lows the peak viremia. This phenomenon may be related to increased cell activation, as has
been suggested by others [20]. In this paper we explored in more detail the activation status of
different CD8+ T cell subpopulations in adult patients with dengue fever.
Fig 3. Proliferation of CD8+ T lymphocytes in dengue fever. (A) Percentage and (B) absolute numbers of Ki67+ within CD8+ T lymphocytes in the
peripheral blood from healthy controls (n = 17) and dengue fever patients (n = 74) at different days of symptoms. *p<0.05, ***p<0.0001.
doi:10.1371/journal.pntd.0003520.g003
Fig 4. Activation of CD8+ T cells in dengue fever. (A) Percentage and (B) absolute numbers of three subpopulations (HLADR+, CD38+HLADR+, and
CD38+) within CD8+ T cells in the peripheral blood from healthy controls (n = 17) and dengue fever patients (n = 74) at different days of symptoms: HLADR+,
CD38+HLADR+, and CD38+. Only the dual positive subpopulation significantly increased during the course of dengue fever, either in their percentage or
absolute numbers. *p< 0.05, ***p< 0.0001.
doi:10.1371/journal.pntd.0003520.g004
CD8+ T Activation in Dengue Fever
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Fig 5. Activation of CD8+ T cells subpopulations in dengue fever. Percentage and absolute numbers of
naïve (A and B), central memory (C and D), effector memory (E and F), and terminal effector memory (G and
H) T CD8+ cells are shown. Increased percentages of activated cells were observed mostly in dual positive
CD38+HLA-DR+ central memory (TCM) (p<0.001) effector memory (TEM) (p<0.0001) and terminal effector
memory (TEMRA) (p<0.01) T cells, although the percentage of CD38+HLA-DR- effector memory (p<0.01)
and terminal effector (p<0.01) T cells were also augmented in dengue fever.
doi:10.1371/journal.pntd.0003520.g005
CD8+ T Activation in Dengue Fever
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During high viral burden, several circulating cells are activated including monocytes [21],
NK cells, CD4+ and CD8+ T cells [8,22,23]. This activation seems to be a natural immune re-
sponse to the pathogen and reflects its efforts to control viral replication. Our results show that
the expanding number of CD8+ T cells was associated with lower viremia, especially later in
the disease course. Dung et al., also demonstrated that activated CD8+ T cell expansion (evalu-
ated by the expression of HLA-DR and CD38 molecules) was associated with viral control
[24]. However, it is possible that high levels of cellular activation may be harmful to the host
and may be related to disease severity. A number of studies have found increased markers of
immune cell activation in patients with dengue hemorrhagic fever (DHF) compared with pa-
tients with classic dengue fever (DF) [25]. Indeed, children who developed DHF had higher
percentages of CD8+ T cells and NK cells expressing CD69, an early activation marker than
those with DF during the febrile period of illness [8,26]. Also, children admitted with acute
dengue fever had increased levels of NK cells and T lymphocyte activation and the severity of
disease was associated with higher activation status [23].
In the last few years considerable progress has been made in identifying different T cell
memory subsets to dissect the heterogeneity of human immune responses [27]. In this paper,
we evaluated in different CD8+ T subpopulations in adults with dengue fever using a compre-
hensive panel of antibodies. Our current study demonstrates differences in activation status
among the various CD8+ T cell subpopulations in dengue fever patients. The percentages and
numbers of effector memory (TEM) cells, characterized by the CCR7-CD27+CD45RA+/- phe-
notype [28], were the most activated in the later phase of the disease, as demonstrated by the
expression of HLADR and CD38 molecules. Other subpopulations also exhibited increased ac-
tivation, including central memory (TCM) and terminally differentiated memory cells
(TEMRA). However this finding was restricted to the percentage and not the absolute numbers
of these two TCM and TEMRA subsets suggesting that TEM cells are the most activated subset
in the later stages of acute dengue fever. TEM cells have immediate effector function, by secret-
ing IL-2, IFNγ, and other cytokines in response to infectious pathogens [29,30,31].
One limitation of our study is the lack of any data regarding antigen-specific responses
since the observed expansion of TEM cells was described in CD8+ T cells using only surface
staining. Further studies using DENV-derived proteins or peptides for stimulation of PBMC
from acute dengue cases are warranted. Antigen-specific CD8+ T cell responses have been re-
cently described in general population from Sri Lanka hyperendemic area, with higher magni-
tude and more polyfunctional responses for HLA alleles associated with decreased
susceptibility to severe disease [32].
DENV-reactive CD8+ T cells are important in the control of viral replication [33] and may
have different responses to different epitopes [34]. DENV serotype-cross-reactivity of CD8+
T cells has also been demonstrated after primary infection [35]. The observed expansion of
TEM cells, which may contain such cells, should be explored in future studies to verify their an-
tigen-specific characteristics [24]. The analysis of human memory T and B cells has the capaci-
ty to identify the antigens that are targeted by effector T cells, thus providing a rational for
vaccine design. In fact, many dengue vaccine candidates have been using replicating virus, in-
cluding chimeric dengue virus [36], which can induce a significant immune reaction against
the vaccine [37] [38] [39].
Based on our findings that different CD8+ T cell subpopulation are activated to different
levels, it may be important to investigate the status of CD8+ T cell differentiation when analyz-
ing antigen-specific responses. Considering the key role of CD8+ T cell activation and antigen-
specific responses in the pathogenesis of dengue fever, further investigation should be con-
ducted to explore the mechanisms of activation pathways in disease pathogenesis.
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Supporting Information
S1 Fig. Analytical strategy to assess the activation of naïve and memory CD8+ T cells. A
gate on single cells was determined by the size in relation to height (FSC-H) and relative area
(FSC-A). Then a gate was made in the total lymphocyte population followed by a gate on the
CD3+ population. Thereafter, two other gates were made in populations of T lymphocytes
(CD4+ and CD8+). Within the population of CD8+ T lymphocyte subpopulations were evalu-
ated naïve and memory from the Boolean analysis, which was made all possible combinations
with the markers CCR7, CD45RA, CD27. Within each population (naïve, TCM, TEM and
TEMRA) a quadrant gate was carried out to evaluate the expression of activation markers
HLA-DR and CD38.
(TIF)
S2 Fig. Analytical strategy to assess the expression of Ki67 in CD8+ T cells. A gate on single
cells was determined using forward scatter height (FSC-H) and relative area (FSC-A). The lym-
phocyte population was delimited followed by a gate on CD3+ cells. CD8+ T cells were identi-
fied within the CD3+ T cells and analyzed for Ki67 expression.
(TIF)
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